Sclerostin quo vadis? - Is this a useful long-term mortality parameter in prevalent hemodialysis patients?

DSpace Repository

Sclerostin quo vadis? - Is this a useful long-term mortality parameter in prevalent hemodialysis patients?

Author: Nowak, Albina; Artunc, Ferruh; Serra, Andreas L.; Pollock, Emily; Krayenbuehl, Pierre-Alexandre; Mueller, Christian; Friedrich, Bjoern
Tübinger Autor(en):
Artunç, Ferruh Hâdi
Published in: Kidney & Blood Pressure Research (2015), Bd. 40, H. 3, S. 266-276
Verlagsangabe: Karger
Language: English
Full text: http://dx.doi.org/10.1159/000368502
ISSN: 1420-4096
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)